Middle East Pharmaceutical Industries Co.

Last Updated:
  • 105.40 SAR
  • 1.30
  • 1.25%
شركة الشرق الأوسط للصناعات الدوائية
أفالون فارما
Symbol : 4016
ISIN : SA160G51UO10
Day Range : -
Turnover Ratio : 0.52
Market : Saudi Exchange
Sector : Pharma, Biotech & Life Science
Latest Announcements
2026-04-21 12:46:00.0Correction announcement from Middle East Pharmaceutical Industries Co. in regards to the Details of the Electronic Voting Feature on the Agenda Items of the Extraordinary General Assembly.
2026-04-20 12:52:00.0Middle East Pharmaceutical Industries Co. calls its shareholders to attend the Extraordinary General Assembly meeting which include the Increase of the company’s capital ( First Meeting )
2026-04-16 12:44:00.0Middle East Pharmaceutical Industries Co. Announces the formation of its Audit Committee.
2026-04-16 12:40:00.0Middle East Pharmaceutical Industries Co. Announces the appointment of the Chairman and Vice Chairman of the Board, the formation of the Board’s Committees, and the appointment of the Board’s Secretary and the Company’s representatives
2026-04-12 05:11:00.0Middle East Pharmaceutical Industries Co. Announces the Results of the Ordinary General Assembly Meeting (First Meeting)

Middle East Pharmaceutical Industries Co. Stock Overview

View Company Profile

Stock Summary

Last Price (SAR) 105.40
Prev. Close 104.100
Day Range 103.00 - 105.90
52WK range
Turnover (M SAR) 11.97
Volume (M) 0.11
Number of Trades 775
Market Cap (M SAR) 2,082.00
Change in Market Cap (M SAR)
VWAP (SAR) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M SAR)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
11-May-2026 Reviewing Agenda Items

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) named Ahmad Shaher Al Tabbaa as the board’s Chairman for the next...

Riyadh - Mubasher: The Capital Market Authority (CMA) approved the request of Middle East Pharmaceutical Industries Company (Avalon Pharma) to...

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with...

Riyadh – Mubasher: The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million...

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) is set to disburse cash dividends worth SAR 15 million,...